Pharmeuropa: Revised Chapter 2.9.3. Dissolution Test for Solid Dosage Forms published for comment

Recommendation
13-15 May 2025
Vienna, Austria
Practical Approaches for USP General Chapter <1058> Compliance in the QC Laboratory
In the Pharmeuropa issue 35.1, a proposal for a revised chapter 2.9.3. Dissolution test for solid dosage forms was published. The deadline for submitting comments is 31 March 2023.
Compared to the monograph published in the 11th Edition of the Ph. Eur., the following changes are proposed:
- "The text has been edited to improve its clarity and to harmonise the terminology;
- the temperature requirement for the dissolution medium is now given with one digit after the decimal point to be consistent with the required accuracy requirement;
- the requirement for the pH value of the buffer solutions is now stated with two digits after the decimal point to be consistent with the required accuracy requirement;
- the section entitled Apparatus 3 (under Procedure) has been updated to indicate that the apparatus can be operated in two different ways (a) by conducting the test in one vessel or (b) by conducting the test using consecutive vessels."
The full text and further details on the revision and can be found, after registration, on the Pharmeuropa website.
Related GMP News
09.05.2025New ECA Guidance on Sampling and Sample Management
07.05.2025Public Consultation on ICH M13B Guideline on Bioequivalence launched in Switzerland
07.05.2025BioPhorum publishes Guidance for ICH Q2(R2) and Q14 Implementation
23.04.2025OTC Drug Production Ceased after FDA Warning Letter
23.04.2025EMA publishes Draft of ICH M13B Guideline on Bioequivalence
16.04.2025EMA publishes four new product-specific Bioequivalence Guidance